{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-044686","form_type":"8-K","ticker":"QSI","cik":"0001816431","company_name":"Quantum-Si Inc","filed_at":"2023-09-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.390654+00:00","generated_at":"2026-06-10T11:00:54.652212+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Quantum-Si appoints biotech executive Amir Jafri to board of directors","bullets":["Amir Jafri appointed to Board, effective September 22, 2023; Board size increased from 8 to 9.","Jafri is founder, President and CEO of Immunicom, a clinical-stage biotech company.","Board determined Jafri is independent under Nasdaq rules; standard non-employee director compensation applies.","John Patrick (Jack) Kenny appointed Chairperson of the Nominating and Corporate Governance Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-044686","json":"https://secwatch.observer/filing/0001140361-23-044686.json","markdown":"https://secwatch.observer/filing/0001140361-23-044686.md","text":"https://secwatch.observer/filing/0001140361-23-044686.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123044686/0001140361-23-044686-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123044686/ef20011016_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T11:00:54.652212+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b7eab56f5","claim":"Amir Jafri was appointed as Director at Quantum-Si Inc.","evidence_excerpt":"On September 15, 2023, the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Amir Jafri to the Board, effective as of September 22, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123044686/0001140361-23-044686-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}